The official blog of the Lung Institute.

U.S. Smoking Rates are Declining

9 Dec 2015
| Under Disease Education, Medical, Smoking | Posted by | 0 Comments
U.S. Smoking Rates are Declining

U.S. smoking rates are declining, according to data presented by the Centers for Disease Control, but vulnerable demographics are still smoking at relatively high rates. According to the CDC, the adult smoking rate is now 16.8% -down from 20.9% in 2005 and 17.8% in 2013. However, not all groups saw such steep declines. For example, adults on Medicaid or those without health insurance smoke at more than twice the rate of adults on Medicare or private insurance. 43% of adults with a GED were smokers, compared to 5% with a university degree. Those living below the poverty line smoke at a rate of 26.3%. The report also found that 18.8% of men smoke, compared to 14.8% of women.

“Disparities are the single most important issue in smoking,” Kenneth Warner, a professor at the University of Michigan School of Public Health, told the New York Times. “The people who are politically influential believe the smoking problem has been solved. It’s not in their neighborhoods. Their friends don’t smoke. Those who still smoke are the poor, the disenfranchised, the mentally ill. That’s who we need to focus on.”

The decline in smoking and waning public regard for second-hand smoke may soon manifest itself in government policy. Federal authorities have proposed a ban on smoking in public housing that, if implemented, would affect more than 700,000 households. In its proposed rule, the Department of Housing and Urban Development would require more than 3,100 public housing agencies to go smoke-free within several years. The agencies must design policies prohibiting lit tobacco products in all living areas, common indoor areas, administrative spaces, and outdoor areas near housing and administrative office buildings, said HUD officials.

Cigarette smoking still kills 480,000 Americans each year, making it the leading preventable cause of death in the United States, according to the Center for Disease Control and Prevention (CDC). Officials primarily cited this health data in justifying the proposed public housing smoking ban, noting especially the risks to children and the elderly people who live in more than 500,000 public housing units.

If you suffer from lung disease and still smoke, the best thing you can do for your health is to kick the habit. If you have been off tobacco for awhile and are looking for treatment options for lung disease, perhaps stem cell treatment is the option you seek. Contact us, or call (800) 729-3065 to find out if you qualify for treatment at the Lung Institute.





Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.